Literature DB >> 18443572

Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients.

Jana Henschkowski1, Andreas E Stuck, Brigitte M Frey, Gerhard Gillmann, Bernhard Dick, Felix J Frey, Markus G Mohaupt.   

Abstract

BACKGROUND: The prevalence of arterial hypertension lacking a defined underlying cause increases with age. Age-related arterial hypertension is insufficiently understood, yet known characteristics suggest an aldosterone-independent activation of the mineralocorticoid receptor. Therefore, we hypothesized that 11beta-HSD2 activity is age-dependently impaired, resulting in a compromised intracellular inactivation of cortisol (F) with F-mediated mineralocorticoid hypertension.
METHODS: Steroid hormone metabolites in 24-h urine samples of 165 consecutive hypertensive patients were analyzed for F and cortisone (E), and their TH-metabolites tetrahydro-F (THF), 5alphaTHF, TH-deoxycortisol (THS), and THE by gas chromatography-mass spectroscopy. Apparent 11beta-HSD2 and 11beta-hydroxylase activity and excretion of F metabolites were assessed.
RESULTS: In 72 female and 93 male patients aged 18-84 years, age correlated positively with the ratios of (THF + 5alphaTHF)/THE (P = 0.065) and F/E (P < 0.002) suggesting an age-dependent reduction in the apparent 11beta-HSD2 activity, which persisted (F/E; P = 0.020) after excluding impaired renal function. Excretion of F metabolites remained age-independent most likely as a consequence of an age-dependent diminished apparent 11beta-hydroxylase activity (P = 0.038).
CONCLUSION: Reduced 11beta-HSD2 activity emerges as a previously unrecognized risk factor contributing to the rising prevalence of arterial hypertension in elderly. This opens new perspectives for targeted treatment of age-related hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443572     DOI: 10.1038/ajh.2008.152

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  12 in total

1.  Hsd11b2 haploinsufficiency in mice causes salt sensitivity of blood pressure.

Authors:  Matthew A Bailey; Eilidh Craigie; Dawn E W Livingstone; Yuri V Kotelevtsev; Emad A S Al-Dujaili; Christopher J Kenyon; John J Mullins
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

2.  Novel CYP11B2 mutation causing aldosterone synthase (P450c11AS) deficiency.

Authors:  Tippayakarn Klomchan; Vichit Supornsilchai; Suttipong Wacharasindhu; Vorasuk Shotelersuk; Taninee Sahakitrungruang
Journal:  Eur J Pediatr       Date:  2012-07-17       Impact factor: 3.183

Review 3.  The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failure.

Authors:  Bertram Pitt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

4.  Bimodal aldosterone distribution in low-renin hypertension.

Authors:  E Victor Adlin; Leonard E Braitman; Ramachandran S Vasan
Journal:  Am J Hypertens       Date:  2013-06-11       Impact factor: 2.689

Review 5.  Glucocorticoid therapy and ocular hypertension.

Authors:  Adnan Dibas; Thomas Yorio
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432

Review 6.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

7.  Born from pre-eclamptic pregnancies predisposes infants to altered cortisol metabolism in the first postnatal year.

Authors:  Fiona Broughton Pipkin; Hiten D Mistry; Chandrima Roy; Bernhard Dick; Jason Waugh; Rebecca Chikhi; Lesia O Kurlak; Markus G Mohaupt
Journal:  Endocr Connect       Date:  2015-09-16       Impact factor: 3.335

8.  Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients.

Authors:  Christiane Drechsler; Eberhard Ritz; Andreas Tomaschitz; Stefan Pilz; Stephan Schönfeld; Katja Blouin; Martin Bidlingmaier; Fabian Hammer; Vera Krane; Winfried März; Bruno Allolio; Martin Fassnacht; Christoph Wanner
Journal:  Eur Heart J       Date:  2012-12-04       Impact factor: 29.983

9.  The clinical significance of aldosterone synthase deficiency: report of a novel mutation in the CYP11B2 gene.

Authors:  Elaine Hui; Matthew Cw Yeung; Pik To Cheung; Elaine Kwan; Louis Low; Kathryn Cb Tan; Karen Sl Lam; Angel Ok Chan
Journal:  BMC Endocr Disord       Date:  2014-04-03       Impact factor: 2.763

10.  Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional study.

Authors:  Michael S Sagmeister; Angela E Taylor; Anthony Fenton; Nadezhda A Wall; Dimitrios Chanouzas; Peter G Nightingale; Charles J Ferro; Wiebke Arlt; Paul Cockwell; Rowan S Hardy; Lorraine Harper
Journal:  Clin Endocrinol (Oxf)       Date:  2018-11-15       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.